| Premier Golden Heart Health Care Services Llc | |
| 2412 Old North Rd Building 101 Suite K, Denton, Texas 76209 | |
| (940) 566-4999 | |
| Not Available |
| Name | Premier Golden Heart Health Care Services Llc |
|---|---|
| Location | 2412 Old North Rd Building 101 Suite K, Denton, Texas |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 677962 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 75077, 75287, 76201, 76205, 76207, 76208, 76209, 76259, 76266 |
| NPI Number | 1033279252 |
| Organization Name | PREMIER GOLDEN HEART HEALTH CARE SERVICES LLC |
| Address | 2412 Old North Rd Ste 101k, Denton, TX 76209 |
| Phone Number | 940-566-4999 |
News Archive
Home is the theme of the first in the new series of lectures by University of Leicester PhD graduates, as they explore how long it takes babies in neonatal care to be sent home and how home-making practices are used by migrants to become familiar with a new place.
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications announced that its Healthcare Division, Spacelabs Healthcare, has been awarded a one-year $13.5 million Indefinite Delivery Indefinite Quantity (IDIQ) contract from the U.S. Defense Supply Center Philadelphia Medical Supplier Operations Directorate to provide patient monitoring systems, sub-systems, training and consumables.
St. Jude Children's Research Hospital scientists have identified a signature immune response that might help doctors identify which newly diagnosed influenza patients are most likely to develop severe symptoms and suffer poor outcomes. The findings also help explain why infants and toddlers are at elevated risk for flu complications. The research appears in the upcoming issue of the American Journal of Respiratory and Critical Care Medicine.
Bioject Medical Technologies Inc., a leading developer of needle-free injection therapy systems (NFITS), today announced that the Centers for Disease Control and Prevention (CDC) and its collaborating institutions presented the latest results of its clinical trial of the Biojector® 2000 at the 13th Annual Conference on Vaccine Research, sponsored by the National Foundation for Infectious Diseases and held in Bethesda, Maryland April 26 - 28, 2010.
Flatulence. Everyone has it. Common factors contributing to flatus production are swallowed air and digestion of certain foods in the intestine. Perhaps one of the most embarrassing aspects of flatulence is the smelly odor, but there is a remedy and it is called Devrom.
› Verified 4 days ago
| Quality Rating: | Not Available* |
| * The number of patient episodes for this measure is too small to report. | |
News Archive
Home is the theme of the first in the new series of lectures by University of Leicester PhD graduates, as they explore how long it takes babies in neonatal care to be sent home and how home-making practices are used by migrants to become familiar with a new place.
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications announced that its Healthcare Division, Spacelabs Healthcare, has been awarded a one-year $13.5 million Indefinite Delivery Indefinite Quantity (IDIQ) contract from the U.S. Defense Supply Center Philadelphia Medical Supplier Operations Directorate to provide patient monitoring systems, sub-systems, training and consumables.
St. Jude Children's Research Hospital scientists have identified a signature immune response that might help doctors identify which newly diagnosed influenza patients are most likely to develop severe symptoms and suffer poor outcomes. The findings also help explain why infants and toddlers are at elevated risk for flu complications. The research appears in the upcoming issue of the American Journal of Respiratory and Critical Care Medicine.
Bioject Medical Technologies Inc., a leading developer of needle-free injection therapy systems (NFITS), today announced that the Centers for Disease Control and Prevention (CDC) and its collaborating institutions presented the latest results of its clinical trial of the Biojector® 2000 at the 13th Annual Conference on Vaccine Research, sponsored by the National Foundation for Infectious Diseases and held in Bethesda, Maryland April 26 - 28, 2010.
Flatulence. Everyone has it. Common factors contributing to flatus production are swallowed air and digestion of certain foods in the intestine. Perhaps one of the most embarrassing aspects of flatulence is the smelly odor, but there is a remedy and it is called Devrom.
› Verified 4 days ago
News Archive
Home is the theme of the first in the new series of lectures by University of Leicester PhD graduates, as they explore how long it takes babies in neonatal care to be sent home and how home-making practices are used by migrants to become familiar with a new place.
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications announced that its Healthcare Division, Spacelabs Healthcare, has been awarded a one-year $13.5 million Indefinite Delivery Indefinite Quantity (IDIQ) contract from the U.S. Defense Supply Center Philadelphia Medical Supplier Operations Directorate to provide patient monitoring systems, sub-systems, training and consumables.
St. Jude Children's Research Hospital scientists have identified a signature immune response that might help doctors identify which newly diagnosed influenza patients are most likely to develop severe symptoms and suffer poor outcomes. The findings also help explain why infants and toddlers are at elevated risk for flu complications. The research appears in the upcoming issue of the American Journal of Respiratory and Critical Care Medicine.
Bioject Medical Technologies Inc., a leading developer of needle-free injection therapy systems (NFITS), today announced that the Centers for Disease Control and Prevention (CDC) and its collaborating institutions presented the latest results of its clinical trial of the Biojector® 2000 at the 13th Annual Conference on Vaccine Research, sponsored by the National Foundation for Infectious Diseases and held in Bethesda, Maryland April 26 - 28, 2010.
Flatulence. Everyone has it. Common factors contributing to flatus production are swallowed air and digestion of certain foods in the intestine. Perhaps one of the most embarrassing aspects of flatulence is the smelly odor, but there is a remedy and it is called Devrom.
› Verified 4 days ago
Anji Home Health Agency Inc Location: 2700 Loon Lake Road, Denton, Texas 76210 Ratings: NA Phone: (940) 535-6036 | |
Arc Home Healthcare Location: 2277 Masch Branch Rd, Denton, Texas 76207 Ratings: Phone: (940) 585-6338 | |
Premier Golden Heart Health Care Services Llc Location: 2412 Old North Rd Building 101 Suite K, Denton, Texas 76209 Ratings: NA Phone: (940) 566-4999 | |
Advanced Rehabtrust Home Health Location: 723 S Ih 35 East Suite 224, Denton, Texas 76205 Ratings: Phone: (940) 384-0393 | |
Texas Home Health Group Of Denton, Llc Location: 2800 Shoreline Drive, #204, Denton, Texas 76210 Ratings: Phone: (940) 891-1161 |